Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Brown

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cellular and Molecular Neurobiology|October 24, 2023
Antioxidant System and Endoplasmic Reticulum Stress in CataractsXi Zhang, Bingqing Liu, Kevin Lal, et al.
The Science of the Total Environment|February 22, 2021
Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewershedsJennifer Weidhaas, Zachary T Aanderud, D Keith Roper, et al.
CJEM|May 7, 2021
A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutterIan G Stiell, Marco L A Sivilotti, Monica Taljaard, et al.
CJEM|August 12, 2021
2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices ChecklistIan G Stiell, Kerstin de Wit, Frank X Scheuermeyer, et al.
Lancet (London, England)|February 3, 2020
Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trialIan G Stiell, Marco L A Sivilotti, Monica Taljaard, et al.
The Canadian Journal of Cardiology|September 2, 2021
Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial FlutterIan G Stiell, Debra Eagles, Marie-Joe Nemnom, et al.
BMJ (Clinical Research Ed.)|November 11, 2025
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trialIan G Stiell, Monica Taljaard, Debra Eagles, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cellular and Molecular Neurobiology|October 24, 2023
Antioxidant System and Endoplasmic Reticulum Stress in CataractsXi Zhang, Bingqing Liu, Kevin Lal, et al.
The Science of the Total Environment|February 22, 2021
Correlation of SARS-CoV-2 RNA in wastewater with COVID-19 disease burden in sewershedsJennifer Weidhaas, Zachary T Aanderud, D Keith Roper, et al.
CJEM|May 7, 2021
A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutterIan G Stiell, Marco L A Sivilotti, Monica Taljaard, et al.
CJEM|August 12, 2021
2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices ChecklistIan G Stiell, Kerstin de Wit, Frank X Scheuermeyer, et al.
Lancet (London, England)|February 3, 2020
Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trialIan G Stiell, Marco L A Sivilotti, Monica Taljaard, et al.
The Canadian Journal of Cardiology|September 2, 2021
Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial FlutterIan G Stiell, Debra Eagles, Marie-Joe Nemnom, et al.
BMJ (Clinical Research Ed.)|November 11, 2025
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trialIan G Stiell, Monica Taljaard, Debra Eagles, et al.
Pageof 3